Hazel Hunt - 09 Feb 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Scientific Officer
Issuer ticker: CORT
Reported as of: 09 Feb 2026
Net transaction value: -$2,638,858
SEC form: 4
Accepted by SEC: 11 Feb 2026, 17:26:28 UTC
Prior SEC filing: 04 Mar 2025
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt

Key filing fact

Hazel Hunt filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 11 Feb 2026.

Key facts

This page summarizes Hazel Hunt's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Feb 2026, 17:26.

Change

Previous filing in this sequence was filed on 04 Mar 2025.
Current net transaction value: -$2,638,858.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698307 Primary reporting owner

Hunt Hazel

Relationship: Chief Scientific Officer
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Signature date: 11 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Options Exercise

Transaction value: $582,000
Shares: +150,000
Change %: +82%
Price: $3.88
Shares after: 333,405
Date: 09 Feb 2026
Ownership: Direct

CORT transaction

Common Stock

Tax liability

Transaction value: $3,220,858
Shares: -77,968
Change %: -23%
Price: $41.31
Shares after: 255,437
Date: 09 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -150,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 09 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $3.88
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 26, 2026.

Footnote F2

Fully exercisable.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.